HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Masanori Ito Selected Research

Pepsinogen A (Pepsinogen)

10/2015Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
2/2014Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
9/2011Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients.
6/2007Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
4/2007Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
9/2006Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia.
1/2004Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
1/2003Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
5/2002Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gastric carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Masanori Ito Research Topics

Disease

24Neoplasms (Cancer)
01/2015 - 07/2002
15Stomach Neoplasms (Stomach Cancer)
02/2014 - 05/2002
12Gastritis
10/2015 - 07/2002
10Infection
05/2014 - 01/2003
6Carcinoma (Carcinomatosis)
01/2008 - 10/2003
4Inflammation
01/2015 - 01/2005
4Microsatellite Instability
06/2009 - 09/2003
4Colorectal Neoplasms (Colorectal Cancer)
01/2007 - 06/2003
3Atrophy
10/2015 - 10/2008
3Obesity
06/2015 - 10/2008
3Gastroesophageal Reflux (GERD)
03/2013 - 09/2006
3Neoplasm Metastasis (Metastasis)
07/2011 - 07/2003
3Duodenal Ulcer (Curling's Ulcer)
12/2010 - 04/2003
2Pain (Aches)
02/2015 - 05/2011
2Membranous Glomerulonephritis (Membranous Nephropathy)
10/2012 - 02/2011
2Proteinuria
10/2012 - 12/2009
2Trigeminal Neuralgia (Tic Douloureux)
05/2012 - 03/2009
2Hemorrhage
01/2012 - 08/2010
2Cysts
02/2011 - 04/2002
2Crohn Disease (Crohn's Disease)
12/2009 - 01/2005
2Anoxia (Hypoxia)
07/2003 - 06/2003
1Endometrial Neoplasms (Endometrial Cancer)
11/2015
1Atrophic Gastritis
10/2015
1Seizures (Seizure)
06/2015
1Myocardial Infarction
03/2015
1Postoperative Pain
02/2015
1Cardiomegaly (Heart Hypertrophy)
02/2015
1Fibrosis (Cirrhosis)
02/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Vascular System Injuries
07/2014
1Neurofibroma
01/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2014
1Peptic Esophagitis (Reflux Esophagitis)
03/2013
1Hepatocellular Carcinoma (Hepatoma)
02/2013
1Hepatitis B
10/2012
1Hematuria
10/2012
1Hemifacial Spasm
05/2012
1Tolosa-Hunt Syndrome
05/2012
1Maxillary Sinusitis
05/2012
1Carotid-Cavernous Sinus Fistula
05/2012
1Fever (Fevers)
01/2012
1Critical Illness (Critically Ill)
01/2012
1Neuralgia (Stump Neuralgia)
01/2012
1Sepsis (Septicemia)
01/2012

Drug/Important Bio-Agent (IBA)

9Pepsinogen A (Pepsinogen)IBA
10/2015 - 05/2002
8GastrinsIBA
05/2014 - 04/2003
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2004 - 06/2003
4Biological Markers (Surrogate Marker)IBA
10/2015 - 01/2005
4InterleukinsIBA
06/2015 - 11/2003
3AdipokinesIBA
06/2015 - 01/2014
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2014 - 02/2004
3ParaffinIBA
12/2010 - 06/2003
3AntigensIBA
01/2009 - 01/2004
3AntibodiesIBA
05/2007 - 01/2003
3N-methylsuccinimideIBA
07/2004 - 09/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2015 - 12/2009
2Neurofibromin 1 (Neurofibromin)IBA
01/2015 - 01/2014
2Hematoxylin (Haematoxylon)IBA
05/2013 - 01/2007
2Eosine Yellowish-(YS) (Eosin)IBA
05/2013 - 01/2007
2Cholecystokinin B ReceptorIBA
03/2013 - 01/2008
2GadoliniumIBA
01/2013 - 04/2009
2Tyrosine (L-Tyrosine)FDA Link
01/2010 - 01/2009
2infliximab (Remicade)FDA Link
12/2009 - 01/2005
2Immunoglobulin G (IgG)IBA
02/2007 - 01/2003
2Interleukin-8 (Interleukin 8)IBA
12/2006 - 02/2004
2CytokinesIBA
01/2006 - 03/2005
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2005 - 11/2003
2Messenger RNA (mRNA)IBA
07/2005 - 06/2003
2Carbon MonoxideIBA
07/2005 - 11/2003
2Mitochondrial DNA (mtDNA)IBA
11/2003 - 08/2003
1ProgesteroneFDA LinkGeneric
11/2015
1AdiponectinIBA
03/2015
1fibroblast growth factor 21IBA
03/2015
1Etodolac (Lodine)FDA LinkGeneric
02/2015
1Angiotensin IIIBA
02/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2015
1celecoxib (Celebrex)FDA Link
02/2015
1rebamipideIBA
01/2015
1FollistatinIBA
07/2014
1Staphylococcal Protein A (A, Protein)IBA
01/2014
1HormonesIBA
01/2014
1Proton Pump InhibitorsIBA
03/2013
1Steroid 12-alpha-Hydroxylase (CYP8B1)IBA
02/2013
1adefovirIBA
10/2012
1progressive familial intrahepatic 1 CholestasisIBA
10/2012
1Lamivudine (3TC)FDA Link
10/2012
1Dental Implants (Dental Implant)IBA
05/2012
1painful OphthalmoplegiaIBA
05/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2012
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2012
1Conotoxins (Conotoxin)IBA
01/2012
1AntipyreticsIBA
01/2012

Therapy/Procedure

3Decompression
05/2012 - 10/2008
3Craniotomy
02/2011 - 09/2008
2Ligation
03/2015 - 01/2012
1Induced Hyperthermia (Thermotherapy)
06/2015
1Gastrectomy
05/2014
1Transplants (Transplant)
10/2012
1Endoscopic Hemostasis
01/2012
1Intensive Care (Surgical Intensive Care)
01/2012